What an Endocrinologist Wants You to Know Before You Switch GLP-1 Medications

By the Get Clear Beauty editorial team · Published August 23, 2026 · How we research pricing

Dr. Ayushi Dixit joined the Get Clear Beauty podcast to talk about medical weight loss, and the conversation went far deeper than the brand names people recognize. She is an endocrinologist with an internal medicine residency, an endocrinology fellowship, and an additional obesity board certification through Columbia, and she treats weight as a medical condition she manages alongside everything else in a patient's chart. What follows is a summary of what she shared. It is informational and is not medical advice, and any decision about these medications belongs with a clinician who knows your full history.

The dosing reset that convinces people a medication failed

Dr. Dixit was emphatic about one point that patients rarely hear before they need it. If you move from one GLP-1 medication to another, you must restart at the lowest dose. The dosing between these drugs is not interchangeable, and you cannot jump from the highest dose of one to the highest dose of the other. She described this as a safety matter, not a formality.

Prices vary by location and provider.

The practical consequence is a pattern she sees often. Someone on a high dose switches because of side effects, begins again at the starting dose, feels almost nothing, concludes the new medication "isn't working," and switches back. Knowing that reset is coming changes how you read those first few weeks.

Hunger is a hormone conversation

Dr. Dixit explained that hunger and weight regulation run on hormones. Ghrelin drives hunger. Leptin, GLP-1, and GIP drive fullness and satiety. Insulin and glucagon handle glucose. All of them interact with a gland in the brain that signals when to eat and when to stop, and that same gland houses the reward system. In some people, she said, the hunger signal does not switch off when it should and the satiety signal does not arrive when it should. She called that signaling "blunted."

There is no routine clinic test for this. Genetic variants that cause obesity can be identified in blood work, but she noted they account for roughly 4% of the population, far fewer than the number of people living with overweight and obesity. For most people these hormones test as normal and fluctuate throughout the day. Diagnosis comes from the whole medical picture, lifestyle, stressors, and listening carefully to what a patient has already tried. She also pointed to sleep, since poor rest is associated with eating more and with weight gain over time, and alcohol disrupts sleep, which compounds the problem.

Food noise was named by patients first

Patients described this phenomenon before clinicians were discussing it. Food noise is the constant, sometimes intrusive stream of thoughts about food: what to eat, how to plan around a bigger meal later, taking inventory, wondering whether it was too much or too little. Dr. Dixit emphasized how mentally taxing that planning becomes on top of an ordinary life. In her practice she hears patients say their food noise is gone. Some even forget to eat, which she noted is not ideal either.

What the medications are, and how the brands differ

Glucagon-like peptide-1 is a hormone the body already makes. Dr. Dixit explained that it slows the digestive system so you feel full, acts on that gland in the brain to stop eating, and affects insulin and glucose regulation, which matters for anyone who is diabetic, prediabetic, or insulin resistant. The medications enhance that existing hormone effect.

The brands confuse people, and the explanation is simple. Ozempic and Wegovy are both semaglutide from one manufacturer. Mounjaro and Zepbound are both tirzepatide from another. Ozempic and Mounjaro are generally reserved for diabetic patients, while Wegovy and Zepbound are intended for weight management. She noted that part of the reason for separate names is to make coverage decisions clearer for insurance companies. Within each pair the drug is identical, and semaglutide and tirzepatide are different chemicals from one another.

Why progress stalls

Dr. Dixit calls it metabolic adaptation. When you lose weight, the body may read the change as starvation and lower both energy expenditure and metabolic rate. As you become a smaller person, the mass that was helping burn calories is gone, so you burn fewer calories and the same intake stops producing loss. This is why the final stretch is the hardest and why yo-yo dieting struggles. She was direct that you will hit a plateau at every dose.

Who is a candidate, and who is not

She described the effect on A1C in type 2 diabetics as remarkable, and stressed that even when weight loss plateaus, the diabetes usually stays well controlled. Beyond that, candidates include people with a BMI of 30 or above, or 27 and above with a related condition such as prediabetes, sleep apnea, high cholesterol, high blood pressure, heart disease, or polycystic ovarian syndrome. She noted that BMI is used largely because it justifies coverage, and that a body scan showing fat mass, muscle mass, and fat distribution is a better assessment, though insurance does not cover it and some gyms offer one.

These medications are not for everyone. She named recurrent pancreatitis, and a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia, which are rare, sometimes familial, and testable genetically. They are not used while breastfeeding, pregnant, or actively trying to conceive, and she urged caution with gastric motility issues, irritable bowel syndrome, ulcerative colitis, and Crohn's disease, which these drugs can aggravate.

Side effects, and what makes them worse

Nausea and vomiting are the most common. Because the drug slows the digestive tract, Dr. Dixit explained that a heavy, greasy, fatty, tomato-based, or spicy meal late at night sits far longer and feels much worse. She advises eating earlier, choosing leaner and lighter food, and limiting alcohol, particularly early on, and she writes tailored meal plans for her patients. She also sees injection-site rashes, which she asks patients to photograph and may respond to by switching medications, and constipation, which sometimes warrants a dose discussion and often improves with fiber. Pancreatitis has appeared more frequently as use has grown, and she was clear that severe abdominal pain radiating through to the back means going to the hospital, because it can be life-threatening. Some people experience no side effects at all.

She is also against spacing doses out or microdosing. She reduces a dose instead, because she wants to know exactly what a patient is taking. She has received hospital calls from patients who spaced doses, then took what they believed was a small amount after time away and had severe side effects. Consistency week after week is where the safety data lives, and once the drug leaves your system, restarting brings back the intense early-days effects.

Compounded versus brand name

Compounded drugs are not made at the manufacturer's site. Brand-name drugs are made at inspected facilities with FDA approval and published safety data. Compounding expanded during the shortage, and Dr. Dixit has seen versions mixed with salts, B12, vitamin C, and peptides. Her concerns are dilution, unknown contents, unknown manufacturing, and the absence of data on whether those versions deliver the long-term cardiovascular and kidney benefits the brands have demonstrated. She acknowledged that patients do lose weight on compounded versions and that cost is a real barrier, and she still prescribes brand because she knows what is inside it.

How to work through insurance

Her advice here is unusually practical. Call your insurance and ask specifically what they cover for weight management as opposed to diabetes, because the answers differ. One detail most people miss is that your employer can opt in or out of covering these drugs, so two people with the same insurer can have different coverage, and sometimes the fix is a conversation with HR. Expect a prior authorization where your prescriber documents BMI and any related conditions, and expect that a denial is still possible even when you meet the guidelines. An appeal follows. She noted that insurers add new hoops every few months, including requests for diet logs. If coverage falls through, look up the manufacturer's cash price, which she said is far more affordable than the retail pharmacy price.

On the idea that medication is cheating

Dr. Dixit pushed back on this firmly. Obesity causes real downstream disease, including type 2 diabetes, high blood pressure, high cholesterol, joint deterioration, and heart disease. She said people tend to view excess weight as a state rather than a disease, and that is the disconnect. It is a disease that needs managing, and the management differs per person based on their other conditions. She also observed that weight loss drugs have existed for decades and people have not always disclosed what they were doing, including smoking to suppress appetite.

Whether you stay on the medication indefinitely depends on your own goals. For diabetic patients who tolerate it well, she sees strong reason to continue given the benefits. For the weight management population, she does not believe anyone should feel locked in, and she is comfortable with patients trying it, stopping, and revisiting later. She monitors patients regularly, does not want anyone losing too much weight, tracks what they are eating, and values a body scan showing muscle mass where one is available.

What she wishes every patient knew

The medication controls appetite and you will likely lose weight, but Dr. Dixit was clear that you cannot continue exactly as before and expect it to carry you, because you plateau at every dose. Her advice is to build toward a routine you can sustain: a tailored meal plan that maintains muscle mass while you are in a calorie deficit, exercise you will actually keep doing, with weight training helping to keep calories burning, and real sleep. She suggests adding one thing every few weeks rather than everything at once. When the effect eventually wears off, the routine is what you fall back on.

If you are weighing the cost of starting, you can compare real medical weight loss prices from providers near you on our medical weight loss price guide.

Thank you to Dr. Ayushi Dixit for such a generous and clear-eyed conversation. You can find her at ayushidixitmd.com and on Instagram at @ayushidixit.

This article is for general education about aesthetic treatments and pricing. It is not medical advice and is not a substitute for a consultation with a licensed provider. Always confirm current pricing and suitability directly with a provider before booking.